Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : MGI Pharma MOGN New patents, anti cancer -- Ignore unavailable to you. Want to Upgrade?

To: David Cathcart who wrote (1145)	12/8/1998 6:12:00 PM
From: Biomaven	Respond to of 1826

Seems like this trial is at standard NCI pace: PROJECTED ACCRUAL: This study will accrue up to 74 patients (37/stratum) in over 3 years. and ... Patients are followed every 4 weeks until death. That's the NCI for you - maybe they know how good MGI-114 is and the bureaucrats just want the trial to last for 20 years. <G> Peter

To: David Cathcart who wrote (1145)	12/11/1998 4:52:00 PM
From: astro	Read Replies (1) \| Respond to of 1826

David, Thanks for the update. I have to remember to check my SI mail box more often. So do you have any idea who cibcop and picasso58 are? Both have some interesting posts. I like what they have to say and I get the feeling from them that we are in for a big surprise. I was a little disappointed with the prostate results, I hoping that 9 of the 14 were going home cured. But it looks like MGI-114 takes longer to act. I still believe we have a big winner here. I've doubled my money, and I'm very happy with that. It just took awhile longer than I would have thought. What's up with that investment bank? It seems weird. Anyway, I get the feeling that we are going to double again. Cibcop and Picasso seem to know that something is up. I just hope that any good news doesn't come out in a bad market ie. Clinton impeachment. Let's shrink those tumors, astro